Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1191374.RAk7yDRye5PMoV5vkU-iBKCKY8pESgmRkJiFmHqqLrgBY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1191374.RAk7yDRye5PMoV5vkU-iBKCKY8pESgmRkJiFmHqqLrgBY130_assertion type Assertion NP1191374.RAk7yDRye5PMoV5vkU-iBKCKY8pESgmRkJiFmHqqLrgBY130_head.
- NP1191374.RAk7yDRye5PMoV5vkU-iBKCKY8pESgmRkJiFmHqqLrgBY130_assertion wasGeneratedBy ECO_0000203 NP1191374.RAk7yDRye5PMoV5vkU-iBKCKY8pESgmRkJiFmHqqLrgBY130_provenance.
- NP1191374.RAk7yDRye5PMoV5vkU-iBKCKY8pESgmRkJiFmHqqLrgBY130_assertion wasDerivedFrom befree-2016 NP1191374.RAk7yDRye5PMoV5vkU-iBKCKY8pESgmRkJiFmHqqLrgBY130_provenance.
- NP1191374.RAk7yDRye5PMoV5vkU-iBKCKY8pESgmRkJiFmHqqLrgBY130_assertion SIO_000772 24922658 NP1191374.RAk7yDRye5PMoV5vkU-iBKCKY8pESgmRkJiFmHqqLrgBY130_provenance.
- NP1191374.RAk7yDRye5PMoV5vkU-iBKCKY8pESgmRkJiFmHqqLrgBY130_assertion evidence source_evidence_literature NP1191374.RAk7yDRye5PMoV5vkU-iBKCKY8pESgmRkJiFmHqqLrgBY130_provenance.
- NP1191374.RAk7yDRye5PMoV5vkU-iBKCKY8pESgmRkJiFmHqqLrgBY130_assertion description "[The median age of patients was 48 years, and 283 (62.6%) were estrogen and/or progesterone receptor (ER/PgR)-positive, 86 (19.0 %) had human epidermal growth factor receptor 2 (HER2)-overexpressing, and 77 (17.0%) had triple-negative early breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1191374.RAk7yDRye5PMoV5vkU-iBKCKY8pESgmRkJiFmHqqLrgBY130_provenance.